Impact of ABCB1 C3435T Polymorphism on Lymph node Regression in Multimodality Treatment of Locally Advanced Esophageal Cancer

• Thomas CR Jr: Current and ongoing progress in the therapy for resectable esophageal cancer. Dis. Esophagus18 , 211–214 (2005).
   PubMed Web of Science ®Google Scholar
• Rouvelas I , ZengW, LindbladM et al.: Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study.World J. Surg.30 , 2182–2190 (2006).
   PubMed Web of Science ®Google Scholar
• Urba SG , OrringerMB, TurrisiA et al.: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.J. Clin. Oncol.19 , 305–313 (2001).
   PubMed Web of Science ®Google Scholar
• Walsh TN , NoonanN, HollywoodD et al.: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.N. Engl. J. Med.335 , 462–467 (1996).
   PubMed Web of Science ®Google Scholar
• Gebski V , BurmeisterB, SmithersBM et al.: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.Lancet Oncol.8 , 226–234 (2007).
   PubMed Web of Science ®Google Scholar
• Jin H -L, Zhu H, Ling T-S, Zhang H-J, Shi R-H: Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J. Gastroenterol.15 , 5983–5991 (2009).
   PubMed Web of Science ®Google Scholar
• Bollschweiler E , HölscherAH, MetzgerR: Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer.Future Oncol.6 , 25–35 (2010).
   PubMed Web of Science ®Google Scholar
• Evans WE , RellingMV: Pharmacogenomics: translating functional genomics into rational therapeutics.Science286 , 487–491 (1999).
   PubMed Web of Science ®Google Scholar
• Vallböhmer D , BrabenderJ, MetzgerR, HölscherAH: Genetics in the pathogenesis of esophageal cancer; possible predictive and prognostic factors.J. Gastrointest. Surg.14 , 75–80 (2010).
   PubMed Web of Science ®Google Scholar
• Metzger R , SchneiderPM, Warnecke-EberzU, BrabenderJ, HölscherAH. Molecular biology of esophageal cancer. Onkologie27 , 200–206 (2004).
   PubMed Web of Science ®Google Scholar
• Weinshilboum R : Inheritance and drug response.N. Engl. J. Med.348 , 529–537 (2003).
   PubMed Web of Science ®Google Scholar
• Li YH , WangYH, LiY, YangL: MDR1 gene polymorphisms and clinical relevance.Yi Chuan Xue Bao33 , 93–104 (2006).
   PubMedGoogle Scholar
• Höfler H , LangerR, OttK, KellerG: Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract.Recent Results Cancer Res.175 , 33–36 (2007).
   PubMedGoogle Scholar
• Jamroziak K , RobakT: Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies.Hematology9 , 91–105 (2004).
   PubMedGoogle Scholar
• Chen S , HuoX, LinY et al.: Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients.Int. J. Hyg. Environ. Health213 , 140–145 (2010).
   PubMed Web of Science ®Google Scholar
• Wu X , GuJ, WuTT et al.: Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.J. Clin.Oncol.24 , 3789–3792 (2006).
   PubMed Web of Science ®Google Scholar
• Sobin LH , WittekindC (Eds): TNM Classification of Malignant Tumors, 6th Edition. John Wiley and Sons, NY, USA (2002).
   Google Scholar
• Schneider PM , Baldus,SE, MetzgerR et al.: Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.Ann. Surg.242 , 684–692 (2005).
   PubMed Web of Science ®Google Scholar
• Baldus S , MönigS, SchröderW et al.: Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation.Pathologe25 , 421–427 (2004).
   PubMed Web of Science ®Google Scholar
• Warnecke-Eberz U , VallböhmerD, AlakusH et al.: ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer.J. Gastrointest. Surg.13 , 1411–1421 (2009).
   PubMed Web of Science ®Google Scholar
• Bollschweiler E : Benefits and limitations of Kaplan–Meier calculations of survival chance in cancer surgery.Langenbecks Arch. Surg.388 , 239–244 (2003).
   PubMed Web of Science ®Google Scholar
• Kaplan E , MeierP: Nonparametric estimation from incomplete observations.J. Am. Stat. Assoc.53 , 457–481 (1958).
   Web of Science ®Google Scholar
• George J , DharaniepragadaK, KrishnamachariS, ChandrasekaranA, SamSS, SunderE: A single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancer.Clin. Breast Cancer9 , 161–165 (2009).
   PubMed Web of Science ®Google Scholar
• Pan JH , HanJX, WuJM, HuangHN, YuQZ, ShengLJ: MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer.Respiration78 , 49–55 (2009).
   PubMed Web of Science ®Google Scholar
• Ni LN , LiJY, MiaoKR et al.: Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia.Med. Oncol. (2010) (Epub ahead of print).
   Web of Science ®Google Scholar
• Okuno T , TamuraT, YamamoriM et al.: Favorable genetic polymorphisms predictive of clinical outcome of chemoradiotherapy for stage II/III esophageal squamous cell carcinoma in Japanese.Am. J. Clin. Oncol.30 , 252–257 (2007).
   PubMed Web of Science ®Google Scholar
• Kimchi-Sarrfaty C , OhJM, KimIW et al.: A ‘silent‘ polymorphism in the MDR1 gene changes substrate specificity.Science315 , 525–528 (2007).
   PubMed Web of Science ®Google Scholar
• Jamroziak K , BalcerczakE, SmolewskiP et al.: MDR1 (ABCB1) gene polymorphisms C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.Hematology58 , 720–728 (2004).
   Google Scholar
• Zhou SF : Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.Xenobiotica38 , 802–832 (2008).
   PubMed Web of Science ®Google Scholar
• Drain S , CatherwoodMA, OrrN et al.: ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma.Leuk. Lymphoma50 , 566–570 (2009).
   PubMed Web of Science ®Google Scholar
• Gao R , ZhangGJ, FuJK, JinX, ZhangMX, LiF: Effect of fractionated irradiation on HIF-1a and MDR1 expression in esophageal cancer cells.NanFang Yi Ke Da Xue Xue Bao30 , 1037–1040 (2010).
   PubMedGoogle Scholar
• Shareef MM , BrownB, ShajahanS et al.: Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-κB and NF-Y activation in oral carcinoma cells.Mol. Cancer Res.6 , 89–98 (2008).
   PubMed Web of Science ®Google Scholar

▪ Website

• International HapMap project www.hapmap.org
   Google Scholar